This biotech is working on an GLP-1 drug that could be better than the Wegovy pill
The Big Market Report Take
This experimental pill helped people lose about 16% of their body weight after about a year of treatment
Not financial advice. The Big Market Report aggregates news for informational purposes only. Nothing on this site constitutes investment advice. Equities and other securities are subject to market risk. Always do your own research and consult a qualified financial advisor before making any investment decisions. Full disclaimer →
Never miss a story
More from this section
- DNO swaps Norwegian shelf assets with Equinor to boost productionYahoo Finance15m ago
- Luxury Stocks Face Most Bearish Sentiment in Years, UBS SaysBloomberg Markets17m ago
- Mazda: War Risk Just Killed The Bull Case (Rating Downgrade)Seeking Alpha23m ago
- PayPay: It Is Time To Buy Japan's Fintech ChampionSeeking Alpha23m ago